Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Employees - 278,
CEO - Mr. Songlin Song,
Sector - Healthcare,
Country - CN,
Market Cap - 505.18M
| Ticker | ZYBT |
| Index | - |
| Curent Price | 10.66 |
| Change | 1.04% |
| Market Cap | 505.18M |
| Average Volume | 275.29K |
| Income | 2.81M |
| Sales | 26.26M |
| Book Value/Share | 0.82 |
| Cash/Share | 0.02 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | - |
| Moving Avg 20days | 72.32% |
| Moving Avg 50days | 99.27% |
| Moving Avg 200days | 111.54% |
| Shares Outstanding | 47.17M |
| Earnings Date | - |
| Inst. Ownership | - |
| Price/Earnings | 179.16 |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | 19.24 |
| Price/Book | 12.97 |
| Price/Cash | 431.78 |
| Price/FCF | 77.96 |
| Quick Ratio | 0.81 |
| Current Ratio | 1.34 |
| Debt/Equity | 0.31 |
| Return on Assets | 4.07% |
| Return on Equity | 7.51% |
| Return on Investment | 7.24% |
| Gross Margin | 59.46% |
| Ops Margin | 18.90% |
| Profit Margin | 10.69% |
| RSI | 67.01 |
| BETA(β) | - |
| From 52week Low | 204.57% |
| From 52week High | -4.82% |
| EPS | 0.06 |
| EPS next Year | - |
| EPS next Qtr | - |
| EPS this Year | - |
| EPS next 5 Year | - |
| EPS past 5 Year | - |
| Sales past 5 Year | - |
| EPS Y/Y | -55.43% |
| Sales Y/Y | -28.00% |
| EPS Q/Q | -57.05% |
| Sales Q/Q | -21.95% |
| Sales Surprise | - |
| EPS Surprise | - |
| ATR(14) | 1.84 |
| Perf Week | 5.96% |
| Perf Month | 51.85% |
| Perf Quarter | 149.65% |
| Perf Year | - |
| Perf YTD | 119.34% |
| Target Price | - |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer